The peri-operative management of anti-platelet therapy in elective, non-cardiac surgery

被引:5
|
作者
Alcock, Richard F. [1 ]
Naoum, Chris [1 ]
Aliprandi-Costa, Bernadette [1 ]
Hillis, Graham S. [1 ]
Brieger, David B. [1 ]
机构
[1] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2006, Australia
关键词
Peri-operative; Anti-platelet therapy; Elective non-cardiac surgery; CORONARY-ARTERY-DISEASE; CARDIAC RISK; MYOCARDIAL-INFARCTION; VASCULAR-SURGERY; ASPIRIN; MORTALITY; VALIDATION; PREDICTORS; PREVENTION; GUIDELINES;
D O I
10.1016/j.ijcard.2011.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular complications are important causes of morbidity and mortality in patients undergoing elective non-cardiac surgery, with adverse cardiac outcomes estimated to occur in approximately 4% of all patients. Anti-platelet therapy withdrawal may precede up to 10% of acute cardiovascular syndromes, with withdrawal in the peri-operative setting incompletely appraised. Objectives: The aims of our study were to determine the proportion of patients undergoing elective noncardiac surgery currently prescribed anti-platelet therapy, and identify current practice in peri-operative management. In addition, the relationship between management of anti-platelet therapy and perioperative cardiac risk was assessed. Methods: We evaluated consecutive patients attending elective non-cardiac surgery at a major tertiary referral centre. Clinical and biochemical data were collected and analysed on patients currently prescribed antiplatelet therapy. Peri-operative management of anti-platelet therapy was compared with estimated perioperative cardiac risk. Results: Included were 2950 consecutive patients, with 516 (17%) prescribed anti-platelet therapy, primarily for ischaemic heart disease. Two hundred and eighty nine (56%) patients had all anti-platelet therapy ceased in the peri-operative period, including 49% of patients with ischaemic heart disease and 46% of patients with previous coronary stenting. Peri-operative cardiac risk score did not influence anti-platelet therapy management. Conclusions: Approximately 17% of patients undergoing elective non-cardiac surgery are prescribed anti-platelet therapy, the predominant indication being for ischaemic heart disease. Almost half of all patients with previous coronary stenting had no anti-platelet therapy during the peri-operative period. The decision to cease antiplatelet therapy, which occurred commonly, did not appear to be guided by peri-operative cardiac risk stratification. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 50 条
  • [1] Peri-operative management of anti-platelet agents
    Hermiz, Samer
    Larsen, Peter
    Galletly, Duncan C.
    Harding, Scott A.
    ANZ JOURNAL OF SURGERY, 2009, 79 (7-8) : 521 - 525
  • [2] Peri-operative cardiac protection for non-cardiac surgery
    Wong, S. S. C.
    Irwin, M. G.
    ANAESTHESIA, 2016, 71 : 29 - 39
  • [3] Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery
    Weber, Michael
    Luchner, Andreas
    Manfred, Seeberger
    Mueller, Christian
    Liebetrau, Christoph
    Schlitt, Axel
    Apostolovic, Svetlana
    Jankovic, Radmilo
    Bankovic, Dragic
    Jovic, Marina
    Mitrovic, Veselin
    Nef, Holger
    Mollmann, Helge
    Hamm, Christian W.
    EUROPEAN HEART JOURNAL, 2013, 34 (11) : 853 - 862
  • [4] Peri-Operative Myocardial Damage in Higher-Risk Patients Undergoing Elective Non-Cardiac Surgery
    Alcock, Richard F.
    Kouzios, Dorothy
    Hillis, Graham
    Brieger, David
    CIRCULATION, 2011, 124 (21)
  • [5] A review of the peri-operative risk stratification assessment tools used for the prediction of cardiovascular complications in non-cardiac surgery
    Magapu, Pradeep
    Haskard, Dorian
    Fisher, Michael
    PERFUSION-UK, 2016, 31 (05): : 358 - 365
  • [6] OBTAIN: a study of the Occurrence of Bleeding and Thrombosis during Anti-platelet Therapy In Non-cardiac surgery
    Howell, Simon J.
    Hoeks, Sanne E.
    Poldermans, Don
    West, Robert M.
    Wheatcroft, Stephen B.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2011, 28 (06) : 456 - 459
  • [7] Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery
    Ho, H. H.
    Lau, T. W.
    Leung, F.
    Tse, H-F.
    Siu, C-W.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S573 - S577
  • [8] Evaluation of the use of anti-platelet therapy throughout the peri-operative period in patients with femoral neck fracture surgery. A retrospective cohort study
    Abdulhamid, Ahmed Kamel
    INTERNATIONAL ORTHOPAEDICS, 2020, 44 (09) : 1805 - 1813
  • [9] Effect of Anti-Platelet Therapy on Peri-Operative Blood Loss in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
    Kapoor, Samir
    Singh, Gurmeet
    Arya, Rajesh Chand
    Singh, Vikrampal
    Garg, Arun
    Ralhan, Sarju
    Gupta, Vivek Kumar
    Mohan, Bishav
    Wander, Gurpreet Singh
    Gupta, Rajiv Kumar
    ANNALS OF CARDIAC ANAESTHESIA, 2022, 25 (02) : 182 - 187
  • [10] Improved peri-operative risk stratification in non-cardiac surgery: going beyond established clinical scores
    Karakas, Mahir
    Koenig, Wolfgang
    EUROPEAN HEART JOURNAL, 2013, 34 (11) : 796 - 798